Trial intelligence / Profile preview

T-614 plus methotrexate in rheumatoid arthritis patients with inadequate response to methotrexate

jRCT2080220778Phase 3

Sponsor
Fujifilm
Start
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing T-614 + methotrexate with Placebo + methotrexate (2 arms).

02

Drugs

iguratimod
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on jRCT2080220778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call